Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (41-50 of 336) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?N Lynn Henry, Daniel F Hayes
Transactions of the American Clinical and Climatological Association|September 3, 2015
Personalized Medicine: Genomics Trials in OncologyDaniel F Hayes, Anne F Schott
The Journal of Clinical Investigation|December 15, 2022
Expanding the reach of HER2-targeted therapies: transformation of an historical paradigmErin F Cobain, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2022
Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast CancerErin F Cobain, Daniel F Hayes
Cancer Investigation|February 9, 2008
The prognostic implications of circulating tumor cells in patients with breast cancerJeffrey B Smerage, Daniel F Hayes
Seminars in Oncology|June 14, 2002
c-erbB-2 in breast cancer: development of a clinically useful markerDaniel F Hayes, Ann D Thor
Current Treatment Options in Oncology|May 2, 2015
Indications for prognostic gene expression profiling in early breast cancerErin F Cobain, Daniel F Hayes
The Oncologist|January 6, 2021
Completing the TranslationRobert T McCormack, Daniel F Hayes
Molecular Oncology|February 24, 2012
Cancer biomarkersN Lynn Henry, Daniel F Hayes
Journal of the National Cancer Institute|September 2, 2011
Do all patients with breast cancer require systemic adjuvant therapy?Jennifer J Griggs, Daniel F Hayes
Pageof 34

Showing results (41-50 of 336) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?N Lynn Henry, Daniel F Hayes
Transactions of the American Clinical and Climatological Association|September 3, 2015
Personalized Medicine: Genomics Trials in OncologyDaniel F Hayes, Anne F Schott
The Journal of Clinical Investigation|December 15, 2022
Expanding the reach of HER2-targeted therapies: transformation of an historical paradigmErin F Cobain, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2022
Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast CancerErin F Cobain, Daniel F Hayes
Cancer Investigation|February 9, 2008
The prognostic implications of circulating tumor cells in patients with breast cancerJeffrey B Smerage, Daniel F Hayes
Seminars in Oncology|June 14, 2002
c-erbB-2 in breast cancer: development of a clinically useful markerDaniel F Hayes, Ann D Thor
Current Treatment Options in Oncology|May 2, 2015
Indications for prognostic gene expression profiling in early breast cancerErin F Cobain, Daniel F Hayes
The Oncologist|January 6, 2021
Completing the TranslationRobert T McCormack, Daniel F Hayes
Molecular Oncology|February 24, 2012
Cancer biomarkersN Lynn Henry, Daniel F Hayes
Journal of the National Cancer Institute|September 2, 2011
Do all patients with breast cancer require systemic adjuvant therapy?Jennifer J Griggs, Daniel F Hayes
Pageof 34